Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-26 08:58 am Sale | 2026-06-24 | 13D | CENTESSA PHARMACEUTICALS PLC S CNTA | FARALLON CAPITAL MANAGEMENT, L.L.C. | 0 0.000% | -9,370,093 (Position Closed) | Filing History |
| 2026-06-24 6:32 pm Purchase | 2026-06-16 | 13D | CENTESSA PHARMACEUTICALS PLC S CNTA | FARALLON CAPITAL MANAGEMENT, L.L.C. | 9,370,093 6.100% | 9,370,093 (New Position) | Filing History |
| 2026-05-15 4:32 pm Purchase | 2026-03-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Pentwater Capital Management LP | 8,170,000 5.300% | 8,170,000 (New Position) | Filing History |
| 2026-05-15 08:19 am Sale | 2026-03-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Avoro Capital Advisors LLC | 11,430,455 7.390% | -3,125,100 (-21.47%) | Filing History |
| 2026-05-13 09:01 am Sale | 2026-03-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Adage Capital Management, L.P. | 8,925,010 5.770% | -1,109,990 (-11.06%) | Filing History |
| 2026-05-06 11:06 am Sale | 2026-03-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | FMR LLC | 6,783,047 7.500% | -4,216,746 (-38.33%) | Filing History |
| 2026-02-17 09:04 am Purchase | 2025-12-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Avoro Capital Advisors LLC | 14,555,555 9.970% | 3,747,475 (+34.67%) | Filing History |
| 2026-02-06 1:11 pm Purchase | 2026-01-30 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | FMR LLC | 10,999,793 12.200% | 2,104,854 (+23.66%) | Filing History |
| 2026-02-05 1:20 pm Purchase | 2025-12-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | FMR LLC | 8,894,939 9.900% | 2,617,696 (+41.70%) | Filing History |
| 2025-11-28 5:11 pm Sale | 2025-11-25 | 13D | CENTESSA PHARMACEUTICALS PLC S CNTA | General Atlantic Cooperatief U.A. | 7,366,818 5.000% | -2,315,000 (-23.91%) | Filing History |
| 2025-11-17 8:53 pm Unchanged | 2025-11-17 | 13D | CENTESSA PHARMACEUTICALS PLC S CNTA | General Atlantic Cooperatief U.A. | 9,681,818 6.600% | 0 (Unchanged) | Filing History |
| 2025-11-14 09:05 am Purchase | 2025-09-30 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Avoro Capital Advisors LLC | 10,808,080 8.060% | 10,808,080 (New Position) | Filing History |
| 2025-11-13 09:06 am Purchase | 2025-09-30 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Adage Capital Management, L.P. | 10,035,000 7.480% | 1,632,000 (+19.42%) | Filing History |
| 2025-11-05 11:30 am Purchase | 2025-09-30 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | FMR LLC | 6,277,243 7.000% | 6,277,243 (New Position) | Filing History |
| 2025-08-12 09:01 am Purchase | 2025-06-30 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Adage Capital Management, L.P. | 8,403,000 6.290% | 1,449,000 (+20.84%) | Filing History |
| 2025-05-12 09:03 am Purchase | 2025-03-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Adage Capital Management, L.P. | 6,954,000 5.220% | 6,954,000 (New Position) | Filing History |
| 2024-11-14 5:43 pm Sale | 2024-09-30 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | EcoR1 Capital, LLC | 3,223,851 2.900% | -2,394,928 (-42.62%) | Filing History |
| 2024-11-14 4:20 pm Sale | 2024-09-30 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -8,774,570 (Position Closed) | Filing History |
| 2024-02-14 5:37 pm Purchase | 2023-12-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | EcoR1 Capital, LLC | 5,618,779 5.800% | 386,500 (+7.39%) | Filing History |
| 2024-02-14 10:13 am Purchase | 2023-12-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | BIOTECHNOLOGY VALUE FUND L P | 8,774,570 9.000% | 1,880,225 (+27.27%) | Filing History |